Skip to Main Content
Georgetown University’s Newspaper of Record since 1920

The Hoya

Georgetown University’s Newspaper of Record since 1920

The Hoya

Georgetown University’s Newspaper of Record since 1920

The Hoya

WIKIMEDIA COMMONS | A feature of DNA called methylation shows promise as a tool to determine cancer progression and treatment response based on blood samples.

Tumor Biology Dissertation Presents New Way of Tracking Melanoma Progression

By Shivali Vora, Senior Science Editor January 24, 2025

An M.D.-Ph.D. candidate in Georgetown University’s tumor biology program defended his dissertation, titled “Molecular Signatures of Treatment Responses in Tumors and Serial Liquid Biopsies in Patients...

Georgetown Medical Student Leads Initiative to Designate Georgetown as a ‘Skin Smart Campus’

Georgetown Medical Student Leads Initiative to Designate Georgetown as a ‘Skin Smart Campus’

By Caleigh Keating November 10, 2023

Georgetown University’s main and medical campuses were recognized as a platinum level “Skin Smart Campus” by the National Council on Skin Cancer Prevention (NCSCP) on Oct. 11 and Nov. 15, respectively. The...

Lombardi Begins Cancer Trial

By Emily Tu September 4, 2015

The Georgetown Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital embarked on a nationwide clinical trial Sept. 1 that will compare two melanoma drugs. ECOG-ACRIN Cancer...

Load More Stories
Donate to The Hoya